Rxo (RXO) Cash from Financing Activities (2021 - 2026)

Rxo (RXO) has 6 years of Cash from Financing Activities data on file, last reported at $28.0 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities rose 300.0% year-over-year to $28.0 million; the trailing twelve-month figure through Mar 2026 stood at $22.0 million (down 98.02% YoY), and the FY2025 full-year result was $1.0 million, down 99.91% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at $28.0 million, up from -$3.0 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $1.1 billion in Q3 2024 and bottomed at -$145.0 million in Q4 2022.
• The 5-year median for Cash from Financing Activities is -$3.0 million (2025), against an average of $52.3 million.
• The widest annual swing landed in 2022, when Cash from Financing Activities tumbled 417.86%; it then surged 27225.0% in 2024.
• A 5-year view of Cash from Financing Activities shows it stood at -$145.0 million in 2022, then surged by 31.03% to -$100.0 million in 2023, then surged by 101.0% to $1.0 million in 2024, then tumbled by 400.0% to -$3.0 million in 2025, then soared by 1033.33% to $28.0 million in 2026.
• The last three Cash from Financing Activities figures came in at $28.0 million (Q1 2026), -$3.0 million (Q3 2025), and -$3.0 million (Q2 2025), per Business Quant data.

Peer Comparison